WuXi Biologics offers expert services for biologics produced from microbial fermentation, focusing on high quality and efficiency. Their microbial product class services cater to various product types, including antibody fragments, enzymes, cytokines, and virus-like particles (VLPs). This offering complements their mammalian-derived services, providing a comprehensive suite of solutions for diverse biologics development needs.
By clearly outlining its microbial-derived product services, WuXi Biologics demonstrates its capability to handle a broader range of biologics production platforms. This diversification is crucial for capturing market share in segments where microbial fermentation is preferred or more cost-effective. It positions WuXi Biologics as a versatile CRDMO capable of meeting diverse client needs, potentially leading to increased project wins and revenue diversification.
Expert services for microbial fermentation-based biologics.
Supports antibody fragments, enzymes, cytokines, and VLPs.
Complements mammalian-derived service offerings.
WuXi Biologics operates globally, with its services supporting clients across various regions in their biologics development and manufacturing endeavors.
Supports antibody fragments, enzymes, cytokines, and VLPs.
Complements mammalian-derived service offerings.
Sign in to save notes on signals.
Sign In